1. Home
  2. ADVM vs AOUT Comparison

ADVM vs AOUT Comparison

Compare ADVM & AOUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVM
  • AOUT
  • Stock Information
  • Founded
  • ADVM 2006
  • AOUT 2020
  • Country
  • ADVM United States
  • AOUT United States
  • Employees
  • ADVM N/A
  • AOUT N/A
  • Industry
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • AOUT Ordnance And Accessories
  • Sector
  • ADVM Health Care
  • AOUT Industrials
  • Exchange
  • ADVM Nasdaq
  • AOUT Nasdaq
  • Market Cap
  • ADVM 94.6M
  • AOUT 93.0M
  • IPO Year
  • ADVM 2014
  • AOUT N/A
  • Fundamental
  • Price
  • ADVM $4.31
  • AOUT $6.58
  • Analyst Decision
  • ADVM Buy
  • AOUT Strong Buy
  • Analyst Count
  • ADVM 5
  • AOUT 1
  • Target Price
  • ADVM $16.60
  • AOUT $19.00
  • AVG Volume (30 Days)
  • ADVM 1.0M
  • AOUT 78.3K
  • Earning Date
  • ADVM 11-07-2025
  • AOUT 12-04-2025
  • Dividend Yield
  • ADVM N/A
  • AOUT N/A
  • EPS Growth
  • ADVM N/A
  • AOUT N/A
  • EPS
  • ADVM N/A
  • AOUT N/A
  • Revenue
  • ADVM $1,000,000.00
  • AOUT $210,381,000.00
  • Revenue This Year
  • ADVM $1,191.10
  • AOUT N/A
  • Revenue Next Year
  • ADVM N/A
  • AOUT $7.08
  • P/E Ratio
  • ADVM N/A
  • AOUT N/A
  • Revenue Growth
  • ADVM N/A
  • AOUT 5.56
  • 52 Week Low
  • ADVM $1.78
  • AOUT $6.28
  • 52 Week High
  • ADVM $8.18
  • AOUT $17.91
  • Technical
  • Relative Strength Index (RSI)
  • ADVM 50.55
  • AOUT 32.04
  • Support Level
  • ADVM $4.18
  • AOUT $6.53
  • Resistance Level
  • ADVM $4.37
  • AOUT $6.88
  • Average True Range (ATR)
  • ADVM 0.20
  • AOUT 0.37
  • MACD
  • ADVM -0.03
  • AOUT -0.01
  • Stochastic Oscillator
  • ADVM 51.58
  • AOUT 22.29

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

About AOUT American Outdoor Brands Inc.

American Outdoor Brands Inc is engaged in the business of providing outdoor products and accessories for hunting, fishing, camping, shooting, and personal security and defense products. The company designs and produces products and accessories, including shooting supplies, rest, vaults, and other related accessories; premium sportsman knives and tools for fishing and hunting; land management tools for hunting preparedness; harvesting products for post-hunt or post-fishing activities; electro-optical devices, including hunting optics, firearm aiming devices, flashlights, and laser grips; reloading, gunsmithing, and firearm cleaning supplies; and survival, camping, and emergency preparedness products.

Share on Social Networks: